Tissue Engineering Market: Current Analysis and Forecast (2021-2027)

Region:Global

Author(s):

Product Code:UMHE21324

Download Sample Report download
Buy the Full ReportStarting from $3500
Published on

July 2021

Total pages

137

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $3500

About the Report

About the Report

Tissue engineering is an interdisciplinary field in which engineering and life science ideas are used to create biological substitutes that restore, maintain, or improve tissue function. Cells and biomolecules are also mixed with scaffolds in this procedure. Scaffolding is a man-made or natural structure that looks like genuine organs. The use of 3D bioprinters to efficiently design in vitro implants, as well as technological advancements in the field of 3D tissue engineerings, such as the replacement of embryo cells with stem cells, organ-on-a-chip technology, and the use of 3D bioprinters to efficiently design in vitro implants, are expected to boost growth. In addition, an increasing government funding for medical and academic research activities would enhance the growth of the market for tissue engineering throughout the forecast period. For instance, according to the National Institutes of Health's (NIH) April 2019 released a list of funding for various research, condition, and disease categories (RCDC), funding for stem cell research and regenerative medicine was USD D 1.8 billion and USD 1.0 billion, respectively, in 2018. The NIH estimated that the two sectors would get USD 1.7 billion and USD 915 million in funding in 2020, respectively. Furthermore, the increase in the prevalence of chronic diseases & trauma emergencies, rise in awareness related to tissue engineering, technological advancements in 3D bio-printing, and potential pipeline products drive the market growth. However, stringent government regulations and the high cost of treatment are estimated to hamper the growth of the market.

Based on materials, the market is fragmented into synthetic materials and biologically derived materials, and others. The biologically derived materials segment generated revenue of USD XX billion in 2020. The market is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX billion by 2027F owing to the advantages such as biologically derived biomaterials are normally used to substitute or repair damaged tissue function and structure.

Based on the application, the market is fragmented into orthopedics and musculoskeletal, neurology, cardiovascular, skin and integumentary, dental, and others. The orthopedics and musculoskeletal segment generated revenue of USD XX billion in 2020 and is anticipated to reach USD XX billion by the year 2027F, growing at a CAGR of XX% over the forecast period (2021-2027). The rise in the prevalence of musculoskeletal disorders is likely to fuel growth to the orthopedics and musculoskeletal segment.

For a better understanding of the market adoption of the Tissue engineering market, the market is analyzed based on its worldwide penetration in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for tissue engineering and generated revenue of USD XX billion in 2020 owing to the advanced technology for diagnosis and treatment of chronic disorders, availability of private and government funding, etc.

Some of the major players operating in the market include Medtronic plc, Zimmer Biomet Holdings, Inc., Allergan plc, Athersys, Inc., ACell, Inc., Organogenesis Holdings Inc., Tissue Regenix Group plc, Stryker Corporation, RTI Surgical, Inc., and Integra LifeSciences Corporation, etc. Several M&A's along with partnerships have been undertaken by these players to boost their presence in different regions.

Global Tissue Engineering Market was valued at USD XX billion in 2020 and is projected to expand significantly with a CAGR of XX% from 2021-2027F. The Global Tissue Engineering Market is expected to witness a boost on account of rapid advances in stem cell research and its increasing application.

Products


Companies

Medtronic plc, Zimmer Biomet Holdings, Inc., Allergan plc, Athersys, Inc., ACell, Inc., Organogenesis Holdings Inc., Tissue Regenix Group plc, Stryker Corporation, RTI Surgical, Inc., and Integra LifeSciences Corporation

Table of Contents

Table of Contents

1 MARKET INTRODUCTION

1.1 Market Definitions

1.2 Objective of the Study

1.3 Limitation

1.4 Stake Holders

1.5 Currency Used in Report

1.6 Scope of the Global Tissue Engineering Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1 Research Methodology for the Global Tissue Engineering Market

2.1.1 Main Objective of the Global Tissue Engineering Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPs UNDER TISSUE ENGINEERING INDUSTRY

6 COVID-19 IMPACT

7 GLOBAL TISSUE ENGINEERING MARKET REVENUE

8 MARKET INSIGHTS BY MATERIALS

8.1 Synthetic Materials

8.1.1 Synthetic Polymer

8.1.2 Others

8.2 Biologically Derived Materials

8.2.1 Collagen

8.2.2 Others

8.3 Others

9 MARKET INSIGHTS BY APPLICATION

9.1 Orthopedics and Musculoskeletal

9.2 Neurology

9.3 Cardiovascular

9.4 Skin and Integumentary

9.5 Dental

9.6 Others

10 MARKET INSIGHTS BY REGION

10.1 NORTH AMERICA TISSUE ENGINEERING MARKET

10.1.1 United States

10.1.2 Canada

10.1.3 Rest of North America

10.2 EUROPE TISSUE ENGINEERING MARKET

10.2.1 Germany

10.2.2 France

10.2.3 United Kingdom

10.2.4 Spain

10.2.5 Italy

10.2.6 Rest of Europe

10.3 ASIA PACIFIC TISSUE ENGINEERING MARKET

10.3.1 China

10.3.2 Japan

10.3.3 India

10.3.4 Australia

10.3.5 South Korea

10.3.6 Rest of Asia Pacific

10.4 REST OF THE WORLD TISSUE ENGINEERING MARKET

11 TISSUE ENGINEERING MARKET DYNAMICS

11.1 Market Drivers

11.2 Market Challenges

11.3 Impact Analysis

12 LEGAL & REGULATORY FRAMEWORK

13 DEMAND AND SUPPLY SIDE ANALYSIS

13.1 Demand Side Analysis

13.2 Supply Side Analysis

13.2.1 Top Product Launches

13.2.2 Top Business Partnerships

13.2.3 Top Merger & Acquisitions

14 VALUE CHAIN ANALYSIS

15 TISSUE ENGINEERING MARKET OPPORTUNITIES

16 TISSUE ENGINEERING MARKET TRENDS & INSIGHTS

17 COMPETITIVE SCENARIO

17.1 Porter's Five forces analysis

17.1.1 Bargaining power of Supplier

17.1.2 Bargaining power of Buyer

17.1.3 Industry Rivalry

17.1.4 Availability of Substitute

17.1.5 Threat of new Entrants

17.2 Competitive Landscape

17.2.1 Company Share, by Revenue

18 COMPANY PROFILED

18.1 Medtronics plc

18.1.1 Key Facts

18.1.2 Business Description

18.1.3 Key Product/Services Offerings

18.1.4 Growth Strategy

18.1.5 SWOT Analysis

18.1.6 Key Financials

18.1.6.1 Revenue Split

18.1.6.2 Financial Overview of Medtronics plc

18.1.7 Recent Developments

18.1.7.1 Product Launch

18.1.7.2 Partnerships

18.1.7.3 Business Expansion and Investments

18.1.7.4 Merger and Acquisition

18.2 Zimmer Biomet Holdings, Inc.

18.3 Allergan plc

18.4 Athersys, Inc.

18.5 ACell, Inc.

18.6 Organogenesis Holdings Inc.

18.7 Tissue Regenix Group plc

18.8 Stryker Corporation

18.9 RTI Surgical, Inc.

18.10 Integra LifeSciences Corporation

19 DISCLAIMER

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022